Paul Industries delivers high-purity water systems for biotech & bioprocessing as a single-source supplier and installer. We design, fabricate, install, passivate, and validate high-purity water systems – the USP Purified Water and Water-for-Injection generation, storage, and distribution loops that a regulated plant runs on – built to the standards your process and your auditors require.
What biotech & bioprocessing need from high-purity water systems
Bioprocessing adds a layer of complexity beyond traditional pharma: living cell cultures, single-use and stainless hybrid trains, bioreactors, and aseptic fill-finish. Cell and gene therapy suites push classification and segregation even harder. The water, piping, and cleanroom systems supporting biologics have to protect sterility and product integrity at every step.
For this work, that means aseptic processing, single-use/stainless integration, WFI and clean steam for bioreactors, and Grade A/B cleanroom segregation – not as an afterthought, but engineered in from the first drawing.
What we deliver
- USP Purified Water (PW) and Water for Injection (WFI) generation – RO/EDI, multi-effect or vapor-compression distillation
- Storage and distribution loops engineered for turbulent flow, hot-water or ozone sanitization, and dead-leg-free design
- Complete generation-through-point-of-use build: skids, tanks, loop piping, instrumentation, and controls
- Sanitization strategy (hot water 80C+, ozone, or clean steam) matched to your monograph and risk profile
- IQ/OQ/PQ support and turnover documentation for the full water system
One accountable partner
Most biotech projects get split between an equipment supplier and an install contractor – and the validation burden falls in the gap between them. Paul Industries closes that gap by self-performing the whole scope, from supply through documented turnover.
Related: High-Purity Water Systems services · Biotech & Bioprocessing solutions · Request a quote
Frequently asked questions
What high-purity water grade do biotech facilities need?
Most biotech operations need USP purified water for buffer and media prep and Water for Injection for final formulation, cell culture, and rinses. Requirements depend on the process step. Paul Industries designs, builds, and validates both grades for biotech sites nationwide. Call 201-450-8280.
Why is endotoxin control critical for biotech water?
Endotoxin is lipopolysaccharide shed from the cell walls of gram-negative bacteria, and the Water for Injection monograph limits it to 0.25 endotoxin units per millilitre. What makes it a distinct problem from microbial count is that it is heat-stable: it survives the sanitisation that kills the organism producing it, so a loop can sanitise successfully and still fail endotoxin. In a biologic process it also matters downstream, because endotoxin carried into a parenteral product is a patient safety issue that purification is expected to control rather than introduce.
What water does cell culture and fermentation require?
Mammalian cell culture media are normally prepared with Water for Injection, both because the product is usually parenteral and because cells are sensitive to contaminants at levels no piping specification would flag. Trace metals released from a rouged or corroding surface affect growth rate, viability and product quality attributes such as glycosylation. Microbial fermentation is often more tolerant and Purified Water may be defensible for some steps, but the decision belongs to process development and quality rather than to engineering, and it should be recorded rather than assumed.
How does biotech buffer prep affect water system sizing?
Buffer preparation is usually the largest single water consumer in a monoclonal antibody facility, and it is the demand most often underestimated because downstream processing uses far more volume than the bioreactor does. The sizing problem is that buffer prep draws in large intermittent batches rather than continuously, so peak instantaneous demand can be several times the average. Sizing generation on average consumption produces a system that cannot fill a buffer tank in the time the schedule assumes. Inline dilution from concentrates reduces both the water demand and the tankage considerably.
What standards apply to biotech high-purity water?
The water quality itself comes from the pharmacopoeial monographs, USP for the United States and the European Pharmacopoeia where product is supplied into Europe, covering conductivity, total organic carbon and microbial limits, with an endotoxin limit additionally applying to Water for Injection. USP general chapter 1231 provides the supporting guidance on system design, sanitisation and monitoring. The hardware is a separate question: ASME BPE governs the piping, surface finish, drainability and documentation. The monograph tells you what the water must be; BPE tells you how to build something that can deliver it.
Can you scale a water system for a growing biotech company?
Yes, and the useful approach is to provide for growth rather than to buy it upfront. Oversizing generation is a common and expensive error, because a still running well below capacity cycles more and a loop sized for future demand runs at low velocity now, which is exactly the condition that causes microbial excursions. The better provisions are physical: space and utility capacity for a second generation unit, distribution headers with capped tees for future points of use, and electrical and steam capacity reserved. Those cost little now and avoid rebuilding later.
What water do single-use bioprocess systems need?
Single-use systems remove the cleaning demand from the wetted path but not the water demand from the process. Media and buffers still have to be prepared, and that is the dominant consumption, so the generation capacity required is barely reduced. What changes is the clean-in-place load, which can fall substantially. Single-use assemblies also arrive pre-sterilised, so the rinse requirement differs from stainless equipment. The common planning error is assuming a single-use facility needs a small water system, then discovering buffer preparation demand is essentially unchanged.
How do you prevent biofilm in a biotech water loop?
Biofilm is prevented hydraulically and thermally rather than chemically. Keep water moving continuously at sufficient velocity through every part of the loop including branches, since stagnation is the precondition for biofilm rather than a contributing factor. Eliminate the geometry that defeats circulation: dead legs, undrainable sections, instrument tees and valve bodies that hold water. Then apply either continuous hot circulation at 80 degrees C or above, or ambient operation with ozone destroyed by ultraviolet before each point of use. Once established, biofilm is far harder to remove than to prevent.
What is the timeline to build a biotech water system?
Timelines vary with capacity and validation scope, from months for a skid and loop to longer for full WFI generation. Shop fabrication in Virginia runs parallel to site work to compress schedule. Paul Industries gives firm timelines after design. Call 201-450-8280.
How is biotech process water validated?
Through the three phase qualification programme. Phase one is typically two to four weeks of daily sampling at every point of use, intended to demonstrate the system can consistently produce specification water and to establish operating ranges. Phase two repeats at reduced frequency over a similar span and confirms consistency, and product is normally permitted after it. Phase three runs a full year of routine monitoring to capture seasonal variation in feed water. Laboratory incubation governs all three, so the timetable cannot be compressed by adding people.
Do biotech pilot plants need the same water quality as commercial?
The quality attributes are identical, because a pharmacopoeial monograph does not scale: Purified Water is Purified Water and Water for Injection carries the same endotoxin limit whether you make one litre or ten thousand. What differs is volume, and therefore the generation and distribution engineering. The qualification obligation also does not shrink, which surprises pilot facilities, since a small compendial loop still needs three phase sampling at every point. That is one of the strongest arguments for point-of-use units or purchased water at genuinely small scale, rather than a miniature loop.
What causes water quality failures in biotech facilities?
The recurring causes are physical rather than chemical. Stagnation at a point of use that is rarely drawn, a dead leg beyond what hygienic design allows, a sanitisation cycle that reaches temperature at the skid but not at the far end of the loop, a failed ultraviolet unit on an ozonated system leaving a section unsanitised, exhausted or channelled carbon letting organics or chloramine through to the membranes, and contaminated sample ports producing results that send the investigation in the wrong direction. Mapping counts against the isometric usually localises the cause quickly.
Can Paul Industries integrate water systems with bioreactors and CIP?
Yes, and the interfaces are where these projects usually fail. A bioreactor skid, a clean-in-place skid and a water loop are frequently supplied by three parties, each qualifying its own equipment to its own boundary, and nobody owns the behaviour across them. Typical symptoms are a loop that meets specification at the skid outlet but cannot deliver the flow a CIP circuit demands, or a point of use sized for sampling being asked to fill a vessel. Define the flow, temperature and pressure required at each connection, and name one party accountable for delivering it.
How do you handle water for a multi-product biotech facility?
A single compendial loop normally serves a multi-product facility without difficulty, because water is a utility rather than a product-contact carryover risk in the way shared processing equipment is. The attention goes to the points of use and what happens downstream of them. Hoses, transfer panels and portable vessels connected at a point of use are shared items and do carry cross-contamination risk, so they need dedicated assignment or validated cleaning. Sampling should also be planned per suite, so an excursion can be localised to an area rather than implicating the whole plant.
What water system supports downstream purification in biotech?
Downstream purification is where the volume is. Chromatography steps consume large quantities of equilibration, wash, elution and regeneration buffer, and ultrafiltration and diafiltration add more, so buffer preparation for downstream typically dwarfs upstream media demand. Most of this is Water for Injection in a parenteral process. The practical consequences are tankage and peak draw rather than water quality: the loop has to refill large buffer vessels within the process schedule, and the generation and storage combination has to recover between batches without the tank sitting full and slow-turning.
Why choose a single-source contractor for biotech water?
Because on a water system the failures cluster precisely at the contract boundaries. A generation vendor demonstrates its skid meets specification at the outlet. A piping contractor installs distribution. A validation consultant writes protocols. Then phase one sampling finds the far end of the loop never reaches sanitisation temperature, or that passivation preceded the final tie-ins so those welds were never treated, and each party can show it met its own scope. Under one contract the party choosing the design is the party who has to prove the water passes, which aligns the incentives.
What biotech requirements do you build to?
For the hardware, ASME BPE including SF4 electropolished product contact surfaces, full drainability and the weld documentation and material traceability the standard expects. For the water itself, the USP monographs for Purified Water and Water for Injection, with the 0.25 endotoxin units per millilitre limit where WFI applies, and the European Pharmacopoeia where product is supplied into Europe. The facility quality system will normally sit under 21 CFR 211, and 21 CFR 610 general biological product standards where the product is a biologic.
Get a single-source quote
Paul Industries designs, fabricates, installs, passivates, and validates – one accountable partner instead of a vendor plus a contractor plus a validation firm. Tell us about your project and we will scope it.
What do biotech and bioprocessing facilities require from a high-purity water system?
| Requirement | What it means |
|---|---|
| Water grade | WFI for buffer and media preparation; Purified Water for wash and CIP duty |
| Peak demand profile | Highly intermittent — large draws for buffer prep, then long quiet periods |
| Sizing risk | Sizing for average demand is the classic error; the loop must hold return velocity during a concurrent draw |
| Distribution | Dead-leg-free, drainable, sanitisable to the far end of every branch |
| Integration | Tie-ins to buffer prep, media prep, bioreactor and CIP skids |
| Construction | ASME BPE, orbital-welded, passivated to ASTM A967 with A380 pre-clean |
| Endotoxin control | Loop design matters more than generation — endotoxin accumulates where organisms grow |
| Qualification | IQ/OQ/PQ with sampling at every point of use |
Do you handle validation, or just installation?
Both, and for biotech water systems the validation is the longer half of the job. Paul Industries executes commissioning and IQ, OQ and PQ including the three-phase performance qualification sampling campaign, which tests every point of use for conductivity, total organic carbon, microbial count and, on Water for Injection, bacterial endotoxin. That campaign is calendar time governed by laboratory incubation and cannot be compressed by adding people, which is why it belongs in the schedule from day one. We also set the alert and action limits and the sanitisation regime against your own trend data rather than a default, because that justification is what an inspector examines.
Can you take a project from design through startup?
Yes. For a biotech facility the reason to hold this scope together is that water problems appear at points of use rather than in the generation skid, and points of use are distribution work. A split scope means an excursion at a drop produces an investigation across contracts in which the skid performs to specification and nobody owns the branch. Design through startup under one contract also means the loop is sized for the velocity it needs rather than for hoped-for future capacity, since an oversized loop never reaches turbulent flow and becomes where biofilm establishes.